Investors and healthcare executives anticipate a rise in IPOs and M&A activity in 2025, with 72% expecting increased transactions in the sector. Confidence is bolstered by high investment activity, particularly in weight-loss drugs, and optimism about market performance, especially in healthcare indices. Geopolitical risks have emerged as the primary concern for investors, with North America remaining the leading transaction region.
Investors and healthcare executives anticipate a rise in IPOs and M&A activity in 2025, with 72% expecting increased transactions in the sector. Confidence is bolstered by high investment activity, particularly in weight-loss drugs, and optimism about market performance, especially in healthcare indices. Geopolitical risks have emerged as the primary concern for investors, with North America remaining the leading transaction region.
Investors anticipate a surge in healthcare IPOs and M&A activity in 2025, with 64% of surveyed companies expecting more public offerings. Confidence is bolstered by significant investment trends, particularly in weight-loss drugs, and a positive outlook for market indices. Geopolitical risks have emerged as the primary concern for investors, with North America leading the transaction landscape.
Investors and healthcare executives anticipate a rise in IPOs and M&A activity in 2025, with 72% expecting increased transactions in the sector. Confidence is bolstered by high investment activity, and 64% of companies surveyed foresee more public offerings, particularly in Europe. Geopolitical risks have surpassed financing challenges as the primary concern for investors, with North America remaining the leading market.
Healthcare executives anticipate a rise in IPOs and mergers in 2025, with geopolitical tensions now seen as the primary risk. A survey reveals that 64% expect more IPOs, while 72% foresee increased M&A activity, particularly in North America. Optimism is reflected in the expected growth of the MSCI World Healthcare Index and the UK’s FTSE 100 by the end of 2025.
Healthcare executives anticipate a rise in IPOs and corporate transactions in 2025, with geopolitical tensions now seen as the primary risk. A survey reveals that 72% expect increased M&A activity, particularly in North America, while confidence in the market is bolstered by a significant interest in weight-loss drugs and a positive outlook for major indices.
Healthcare executives anticipate a rise in IPOs and corporate transactions in 2025, with geopolitical tensions now viewed as the primary risk to the sector. A recent survey indicates that 64% expect more IPOs, while 72% foresee increased M&A activity, particularly in North America. Confidence in the market is bolstered by significant investment activity, with a notable focus on weight-loss drugs, which 47% believe will have a lasting impact.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
